Proof — Case Study
Flonase
Flonase
One dose. Six allergens.
Most allergy pills block one allergic substance. Flonase blocks six. Consumers just didn't know it yet.
The Work
The Video Ad
The Education Video
The Story
Flonase challenged us to craft a new Science Story™ to defend its leadership against challenger brands in a crowded allergy segment. Our research revealed the white space: most allergy pills block only one allergic substance, leaving millions combining medicines for complete relief.
Flonase's formula blocks six key allergic substances — relieving congestion, runny nose, and itchy, watery eyes, not just sneezing. The Science Story™ landed on one line: one daily dose relieves six symptoms for 24 hours. We produced Ad-to-Education Sequences™ for every SKU, across Amazon, Walmart, social, and digital.
- Science Story™
- Ad-to-Education Sequences™ per SKU
- Video Ads
- Education Videos
Results
6 allergens blocked
vs. one for most allergy pills
Every SKU
Sequences across Amazon, Walmart, social, digital
"They were incredible partners. They kept me in the loop on deliverables and did an excellent job of providing beautiful creative options and taking my team's feedback. I couldn't be happier with the end product."
Brand Manager — Flonase
More work
Case StudyHealthCareAislePrivate label, public proof.View →Case StudyiVIZIAWe see a better way.View →Case StudyLotriminAthlete's foot loves a comeback.View →Case StudyMetrum Research GroupComplexity, distilled.View →Case StudyNexium 24HRBold claims win.View →Case StudyQunol10x better absorption.View →Case StudyVera TherapeuticsClinical data, communicated.View →Case StudyBausch + Lomb83 studies. 35 new claims. Three weeks.View →Case StudyCheers Health — MOAScience, share-worthy.View →Case StudyCheers HealthThree weeks, not six months.View →Case StudyDesigns for HealthNot all vitamin D is equal.View →Case StudyEmerson Logistics1 order. 1 truck. 1 payment.View →